Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.15 | 22.87 |
PEG Ratio (TTM) | -0.07 | 1.16 |
P/S Ratio (TTM) | 1.07 | 1.48 |
P/B Ratio (TTM) | 1.68 | 5.64 |
P/FCF Ratio (TTM) | -3.35 | -29.20 |
Price to 5YR AVG Earnings Ratio | -0.11 | 16.94 |
Price to 5YR AVG FCF Ratio | -1.13 | 14.47 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -39.08% | 4.96% |
ROE (TTM) | -80.79% | 26.60% |
Net Profit Margin (TTM) | -45.20% | 4.54% |
ROIC 5YR AVG | -101.76% | 15.00% |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 21.81% | 21.85% | 35.47% |
Revenue | 31.72% | -12.92% | -16.49% |
Net Income | 11.85% | 2.04% | 6.80% |
Cash Flow | -402.39% | -77.63% | -27.59% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.16 | 1.75 |
Quick Ratio (TTM) | 0.68 | 0.99 |
D/E Ratio (TTM) | 0.26 | 1.49 |
Interest Coverage (TTM) | -14.63 | 21.00 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 3.88 |
LTL to 5YR AVG FCF | -0.14 | 4.85 |
Shares Outstanding Growth 5YR AVG | 66.49% | -6.29% |